Press review
Media
Press articles and media passages dealing with cases of meningiomas linked to Androcur, Lutéran, Lotényl, of testimonies and actions in justices of the victims, of scientific publications.
December 21, 2024
News
Media
Help scandal on the progestogen Androcur: Emmanuelle recounts her "trying but essential" fight
November 24, 2024
News
Legal procedures
Media
Androcur: Amavea files a complaint against X for endangering others and aggravated deception
Press contact
Emmanuelle Huet-Mignaton
contact@amavea.org
06 07 58 67 96
The press kit is available for free download.
-
Vidal: progestins and risk of meningioma: a class effect?
Lire la suitehttps://www.vidal.fr/actualites/30117-progestatifs-et-risque-de-meningiome-un-effet-de-classe.html By David Paitraud – Publication date: March 14, 2023 – Reading:…
: VIDAL : Progestatifs et risque de méningiome : un effet de classe ? -
The practitioner's review: progestins and risk of meningioma: should we cry to the wolf?
Lire la suiteArticle here: https://www.larevuedupraticien.fr/article/progestatifs-et-risque-de-meningiome-faut-il-crier-au-loup Note from the association: It is important to remember that these medications are not…
: LA REVUE DU PRATICIEN : Progestatifs et risque de méningiome : faut-il crier au loup ? -
The daily life of the progestin and mildewness of meningioma: gynecologists are alarmed by the excessive recourse to the precautionary principle
Lire la suiteArticle here: https://www.lequotidiendumedecin.fr/actus-medicales/medicament/progestatifs-et-surrisque-de-meningiome-les-gynecologues-salarment-du-recours-excessif-au-principe? “A major first for a health agency: the precautionary principle…”
: LE QUOTIDIEN DU MEDECIN Progestatifs et surrisque de méningiome : les gynécologues s’alarment du recours excessif au principe de précaution -
Méningiomes under progestin: ANSM creates a committee to assess the risks
Lire la suiteMeningioma under progestin therapy: ANSM creates a committee to assess the risks. IMPORTANT: The association is…
: Méningiomes sous progestatif : l’ANSM crée un comité pour évaluer les risques
